Sprouts Farmers Market Picks up All Nine SKUs of KOIOS and Fit Soda

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the "Company" or "Koios") is pleased to announce that its KOIOS ™ nootropic beverages and Fit Soda ™ functional beverages (collectively, "Koios Beverages") have been approved for placement at Sprouts Farmers Market ("Sprouts") (NASDAQ: SFM) who has more than 360 stores in 23 states. With the addition of Sprouts, the brand will now be carried in more than 4,200 stores across various regions of the United States.

Sprouts inspires wellness naturally with a carefully curated assortment of better-for-you products and a strong focus on customer service among its more than 35,000 team members. Team members are trained to educate customers about the thousands of products offered, which also include cutting-edge vitamins and supplements made using strict quality standards and ethically sourced ingredients. In addition to personalized service, Sprouts offers resources on sprouts.com to educate customers on health topics such as nootropics and cognitive health.

The following SKUs of Koios Beverages will be available in Sprouts beginning in April 2021:

KOIOS ™ Nootropic Beverage: KOIOS ™ is designed to naturally support focus, memory, mental drive, clarity, and energy.

  • Apricot Vanilla
  • Black Raspberry
  • Blood Orange
  • Peach Mango
  • Pear Guava

Fit Soda ™ Functional Beverage: Fit Soda ™ is designed to deliver nutrients to the body, but still taste like soda. It is infused with BCAAs and electrolytes.

  • Black Cherry Cola
  • Orange Cream
  • Root Beer Vanilla Float
  • Sparkling Citrus

Koios Chief Executive Officer Chris Miller commented, "As a company centered in health and wellness, we're thrilled to partner with Sprouts as our first national retail partner to carry all nine SKUs simultaneously. Our products are designed to support cognitive function and nutrition, which meets the needs of Sprouts' shoppers who are looking for innovative and differentiated products made with quality ingredients."

On behalf of the Board of Directors of the Company,

KOIOS BEVERAGE CORP.

"Chris Miller"

Chris Miller, CEO, and Director

For further information, please contact:

Gina Burrus
844-255-6467
gina@koiosbeveragecorp.com

THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

About Koios Beverage Corp.

The Company is an emerging functional beverage company which has an available distribution network of more than 4,400 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.

Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com .

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Potential placements following Sprouts' approval of Koios Beverages to be placed in their supermarkets in the United States. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company's management to predict all risk factors, nor can the Company assess the impact of all factors on Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.

The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company's products will vary from person to person. No claims or guarantees can be made as to the effects of the Company's products on an individual's health and well-being. The Company's products are not intended to diagnose, treat, cure, or prevent any disease.

This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
canadian finance minister chrystia freeland

Cannabis Round-Up: Canadian Finance Minister Knew About Industry's "Financial Distress"

US Vice President Kamala Harris met with recipients of President Joe Biden's Pardon for the Offense of Simple Possession of Marijuana as part of the Democrats' cross-country campaign trail. She urged the Drug Enforcement Administration (DEA) to release its findings on rescheduling cannabis "as quickly as possible."

Meanwhile, as Massachusetts pushes for broader cannabis clemency, Hawaii has passed an amended expungement bill that will institute a pilot program instead of automatic expungements for low-level cannabis convictions.

Stay up to date on the latest news, trends and policy developments in the cannabis industry with our round-up below.

Keep reading...Show less

Goodness Growth Holdings to Release Fourth Quarter and Full Year 2023 Results on March 28, 2024

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that it will release its financial results for its fourth quarter and full year ended December 31, 2023 on Thursday, March 28, 2024 after the market closes.

Goodness Growth management will host a conference call with the investment community that same day, Thursday, March 28, 2024 at 4:30 p.m. ET (3:30 p.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 3718174.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Speak at the 36th Annual Roth Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 36 th Annual Roth Conference on Monday, March 18, 2024, at 8:30AM PT.

A live webcast will be available on the Investors section of the Company's website at https://ir.thecronosgroup.com/events-presentations .

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Trulieve to Open Express Medical Cannabis Dispensary in Palm Bay, Florida

New location is the Company's second dispensary dedicated to express pickup orders

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new express medical cannabis dispensary in Palm Bay, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
canadian parliament building

Cannabis Round-Up: Canadian Committee Paves Way for Excise Tax Changes, MSO Reports Record Revenue

After years of lobbying, the Canadian federal government took an important step that may soon result in a reduction to the high excise tax rates paid on cannabis products.

Meanwhile, the University of British Columbia is embarking on a new clinical study that looks into the effects cannabidiol (CBD) may have on the symptoms of bipolar depression, and Verano Holdings (OTCQX:VRNOF) reported good news for shareholders.

Stay up to date on the latest news, trends and policy developments in the cannabis industry with our round-up below.

Keep reading...Show less

Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹

Ended 2023 with approximately $862 million in cash and short-term investments

Commenced sales to Australian partner

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×